Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Maharashtra FDA begins...

    Maharashtra FDA begins raids on Non Compliant retailers and wholesalers

    Written by Geeta Sharma Sharma Published On 2016-04-17T13:54:12+05:30  |  Updated On 17 April 2016 1:54 PM IST
    Maharashtra: Stocks of medicines worth Rs. 3 Lakh have been seized from a Mumbai based firm, by the Maharashtra Food and Drug Administration (FDA) in an ongoing drive against non-compliance to Drugs and Cosmetics Act (D&C Act). The firms Licenses have been cancelled for violation of Section 18(C) of D&C Act.

    The Maharashtra FDA team along with the police raided another firm in Beed district to discover a stock of 470 bottles of codeine containing cough syrup - Rincoff and Kuffcare C and also 7400 tablets of Alprazolam - Zolam 0.5.

    While one arrest was made , an FIR under the &C Act, Narcotic Drugs and Psychotropic Substances Act, 1985 (NDPS Act) and sections under Indian Penal Code (IPC) was also registered against two people.

    Under the NDPS Act, it is illegal for a person to produce, manufacture, cultivate, possess, sell, purchase, transport, store, and/or consume any narcotic drug or psychotropic substance.

    The state regulator recently also detected a case of a Mumbai based firm which mixed ayurvedic drugs with allopathic medicines in contravention to the provisions of the Drugs and Magic Remedies (Objectionable advertisement ) Act (DMR Act) 1954.

    Products seized belonged to Rajasthan Herbal International, Ayurvedic Park, Jhunjhunu, Rajasthan and Hurni Herboceuticals, Rajasthan.

    The intelligence Branch of the Maharashtra FDA also seized a stock of Leucwin Syrup, Leucwin Capsules, Kaya Cure Churna, Nari Amrut Syrup, Diab Hari Churna, Raj Pro Xtra Power, Mood on Forever Capsule based on a tip-off.

    Advertisements of ayurvedic drugs were also being published in newspapers ,wherein drugs were shown to cure ailments like cancer, hormonal disturbances, female genital tract problems, erectile dysfunction, premature ejaculation, enhancing the breast cup size, etc reports Pharmabiz

    The DMR Act seeks to curtail undesirable advertisements pertaining to drugs and magic remedies as advertising is considered to encourage self medication of harmful drugs. The Act lists the diseases and disorders in respect of which advertising is banned under Section 3 of the Drugs and Magic Remedies Act, 1954.

    The main objective of DMR Act is to control the advertisement of drugs in certain cases and to prohibit the advertisement connected with remedies alleged to posses magic qualities and related matters.
    1954.1985ayurvedic drugsD&C ActDMR ActDrugs and Cosmetics ActDrugs and Magic Remedies ActFDAIPCMaharashtra Food and Drug AdministrationNarcotic Drugs and Psychotropic Substances ActNDPS Actnon-compliance
    Source : Inputs from Pharmabiz

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Geeta Sharma Sharma
    Geeta Sharma Sharma
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok